Press "Enter" to skip to content

Dr Reddy’s launches generic testosterone gel in US market

Citing IQVIA Health data for the 12 months ended February 2019, the company said AndroGel brand and generic versions had US sales of around USD 815.6 million.​​​

Original source:

Also Read:   Hiring Trends in Pharma Industry in 2021